Similar articles

• Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men.

  Hommes MJ, Romijn JA, Endert E, Eeftinck Schattenkerk JK, Sauerwein HP. Hommes MJ, et al. Metabolism. 1991 Jun;40(6):651-6. doi: 10.1016/0026-0495(91)90059-6. Metabolism. 1991. PMID: 1865829
• In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.

  Haugaard SB, Andersen O, Hansen BR, Andersen UB, Vølund A, Iversen J, Nielsen JO, Madsbad S. Haugaard SB, et al. Metabolism. 2005 Feb;54(2):171-9. doi: 10.1016/j.metabol.2004.08.009. Metabolism. 2005. PMID: 15690310 Clinical Trial.
• Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.

  Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Grunfeld C, et al. J Clin Endocrinol Metab. 1992 May;74(5):1045-52. doi: 10.1210/jcem.74.5.1373735. J Clin Endocrinol Metab. 1992. PMID: 1373735
• The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.

  Crook M. Crook M. Ann Clin Biochem. 2007 May;44(Pt 3):219-31. doi: 10.1258/000456307780480828. Ann Clin Biochem. 2007. PMID: 17456292 Review.
• Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection.

  Samaras K. Samaras K. J Antimicrob Chemother. 2008 Feb;61(2):238-45. doi: 10.1093/jac/dkm475. Epub 2007 Dec 10. J Antimicrob Chemother. 2008. PMID: 18070830 Review.